Search

everythinglearnresearchcommunity

for

Search:↓

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Integrin-linked kinase is crucial for normal skin healing.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Tofacitinib is effective and safe for treating alopecia areata.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Blocking certain immune signals can reduce skin damage from radiation therapy.

c-Kit is important for heart regeneration and cancer development.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Oral JAK inhibitors help regrow hair in alopecia patients.